Heron Therapeutics, Inc. (HRTX)

Heron Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	18.39	28.68	15.36	90.54	105.14	71.9
Short-Term Investments	48.96	51.73	69.49	67.04	103.35	319.07
Cash & Short-Term Investments	67.35	80.41	84.85	157.58	208.49	390.97
Cash Growth	102.58%	-5.24%	-46.15%	-24.42%	-46.67%	17.63%
Receivables	73.71	60.14	52.05	35.5	41.85	39.88
Inventory	42.86	42.11	54.57	48.38	41.91	24.97
Prepaid Expenses	7.25	6.12	13.96	12.96	21.95	23.25
Total Current Assets	191.17	188.77	205.44	254.42	314.2	479.06
Property, Plant & Equipment	20.04	25.6	29.81	33.56	39.01	33.37
Other Long-Term Assets	6.93	8.13	15.71	17.72	0.35	0.35
Total Assets	218.14	222.51	250.95	305.71	353.56	512.78
Accounts Payable	10.23	3.24	3.23	3.8	0.53	2.76
Accrued Expenses	29.88	73.37	76.44	62.26	89.22	84.05
Short-Term Debt	-	-	-	-	7.05	5.62
Current Portion of Leases	3.19	3.08	2.69	2.42	3	1.93
Other Current Liabilities	37.02	-	-	2.58	2.7	2.35
Total Current Liabilities	80.32	79.69	82.36	71.06	102.5	96.71
Long-Term Debt	174.23	173.75	149.28	149.08	-	-
Long-Term Leases	1.29	2.8	5.5	8	14.56	12.24
Other Long-Term Liabilities	0.24	0.24	0.24	-	-	-
Total Liabilities	256.08	256.48	237.38	228.14	117.06	108.95
Common Stock	1.52	1.5	1.19	1.02	0.91	0.9
Additional Paid-In Capital	1,879	1,871	1,808	1,690	1,628	1,568
Retained Earnings	-1,918	-1,906	-1,795	-1,613	-1,393	-1,165
Comprehensive Income & Other	-0.01	0.01	-0.02	-0.01	0.26	0.09
Shareholders' Equity	-37.94	-33.97	13.57	77.57	236.49	403.84
Total Liabilities & Equity	218.14	222.51	250.95	305.71	353.56	512.78
Total Debt	178.71	179.63	157.48	159.5	24.61	19.79
Net Cash (Debt)	-111.37	-99.22	-72.63	-1.92	183.88	371.18
Net Cash Growth	-	-	-	-	-50.46%	13.23%
Net Cash Per Share	-0.72	-0.72	-0.67	-0.02	2.03	4.54
Filing Date Shares Outstanding	151.67	150.33	119.26	102.14	91.4	90.37
Total Common Shares Outstanding	151.58	150.29	119.16	102.01	91.31	90.3
Working Capital	110.85	109.09	123.08	183.37	211.69	382.36
Book Value Per Share	-0.25	-0.23	0.11	0.76	2.59	4.47
Tangible Book Value	-37.94	-33.97	13.57	77.57	236.49	403.84
Tangible Book Value Per Share	-0.25	-0.23	0.11	0.76	2.59	4.47
Machinery	-	36.55	35.81	36.37	32.73	27.44
Leasehold Improvements	-	0.65	0.65	0.61	0.88	0.21

Source: S&P Capital IQ. Standard template. Financial Sources.